Understanding time to peak effect of propofol as sole agent on bispectral index in children aged 2-12 years

Gil Gavel1,2, Gilbert Koch3, Axel Terrier4

  • 1St. Anna Kinderspital, Wien, Austria.

PubMed

Insights

Propofol

Area of Science:

  • Pharmacology
  • Pediatric Anesthesia
  • Pharmacokinetics

Background:

  • Previous propofol pharmacodynamic studies in children were potentially confounded by co-administered drugs.
  • Age-dependent differences in propofol onset have been suggested but not definitively established.
  • This study aimed to isolate the effects of age and weight on propofol's hypnotic onset.

Purpose of the Study:

  • To characterize the influence of age and weight on the onset of propofol's hypnotic effects in children.
  • To determine the time to peak propofol effect-site concentration without confounding medications.
  • To compare propofol's onset in younger (2-6 years) versus older (8-12 years) children.

Main Methods:

  • Prospective observational cohort study of 46 healthy children (2-12 years).
  • Propofol administered via target-controlled infusion using the Paedfusor model.
  • Bispectral Index (BIS) and infusion pump data recorded; nonlinear mixed-effects modeling used.

Main Results:

  • Time to peak propofol effect-site concentration was significantly influenced by age and weight (p < .01).
  • Older children (8-12 years) had a longer time to peak effect (99 secs) compared to younger children (2-6 years) (84 secs).
  • Weight also affected time to peak effect, with heavier children (30-63 kg) showing longer onset times (99 secs) than lighter children (11-25 kg) (82 secs).

Conclusions:

  • Both age and weight significantly influence the time to peak propofol effect in children.
  • In the absence of opioids and benzodiazepines, propofol's onset is approximately 20% longer in older children (8-12 years) compared to younger children.
  • These findings highlight the importance of individualized propofol dosing titration based on age and weight.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
113
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
242
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
404
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
317
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
231